跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIGLUSTAT DIPHARMA 100 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MIGLUSTAT DIPHARMA 100 MG CAPSULAS DURAS EFG
Approved
STANDARD
MIGLUSTAT DIPHARMA 100 MG CAPSULAS DURAS EFG
Dipharma Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 9, 2022
Approval ID
7564fdfe7d68f843
Company
Dipharma Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
7564fdfe7d68f843
Drug Cima Aemps Name
MIGLUSTAT DIPHARMA 100 MG CAPSULAS DURAS EFG
Register Number
1181346002
Holder Company Name
Dipharma Arzneimittel Gmbh
Marketing Company Name
Aurovitas Spain, S.A.U.
Holder Company Detail Path
/organization/dipharma-arzneimittel-gmbh
Authorization Date
2022-05-09
Dosage Form
CÁPSULA DURA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Dipharma Arzneimittel Gmbh
Company Detail Path
/organization/dipharma-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
DIPHARMA Arzneimittel GmbH
Country Name
Germany
City Name
limburg,hessen,country_de
Address
Offheimer Weg 33
Active Ingredients
MIGLUSTAT
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 9, 2022
Approval ID
7564fdfe7d68f843
Type
Standard
Back to CIMA-AEMPS Approvals
